Through the 90-day period concluding February 19, 2026, Dyne Therapeutics's top three insider stakeholders include TenPercentOwner Venture Fund Xi, L.P. Atlas (6.56Mn shares), Director Dirk Kersten (5.40Mn shares), TenPercentOwner Venture Opportunity Fund I, L.P. Atlas (2.31Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Fund Xi, L.P. Atlas | 6,562,578 | 28 Feb, 2024 | |
| Dirk Kersten | 5,400,545 | 10 Dec, 2024 | |
| Venture Opportunity Fund I, L.P. Atlas | 2,306,079 | 05 Mar, 2024 | |
| Jason P Rhodes | 1,958,427 | 29 Jan, 2025 | |
| Venture Opportunity Fund Ii, L.P. Atlas | 934,581 | 14 Dec, 2022 | |
| Joshua T Brumm | Ceo & President | 537,998 | 12 Mar, 2024 |
| John Cox | Ceo & President | 394,877 | 17 Feb, 2026 |
| Oxana Beskrovnaya | Chief Scientific Officer | 195,840 | 13 Mar, 2025 |
| Douglas Kerr | Chief Medical Officer | 172,510 | 17 Feb, 2026 |
| Johanna Friedl-Naderer | Chief Commercial Officer | 154,729 | 17 Feb, 2026 |
| Wildon Farwell | Chief Medical Officer | 143,222 | 20 Aug, 2024 |
| Jonathan Mcneill | Chief Business Officer | 132,106 | 20 Aug, 2024 |
| Susanna Gatti High | Chief Operating Officer | 131,636 | 19 Sep, 2024 |
| Erick Lucera | Chief Financial Officer | 131,100 | 17 Feb, 2026 |
| Richard William Scalzo | Svp And Head Of Finance & Admin. | 122,330 | 13 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Feb, 2026 | John Cox | Common Stock | A | 180,000 | $0.00 | 376,877 | D | A |
| 12 Feb, 2026 | Erick Lucera | Common Stock | A | 65,000 | $0.00 | 131,100 | D | A |
| 12 Feb, 2026 | Douglas Kerr | Common Stock | A | 85,000 | $0.00 | 172,510 | D | A |
| 12 Feb, 2026 | Johanna Friedl-Naderer | Common Stock | A | 60,000 | $0.00 | 154,729 | D | A |
| 05 Dec, 2025 | John Cox | Common Stock | D | 2,662 | $20.72 | 196,877 | D | S |
| 05 Dec, 2025 | Douglas Kerr | Common Stock | D | 880 | $20.72 | 87,510 | D | S |
| 05 Dec, 2025 | Johanna Friedl-Naderer | Common Stock | D | 144 | $20.72 | 94,729 | D | S |
| 05 Sep, 2025 | John Cox | Common Stock | D | 2,640 | $13.41 | 199,539 | D | S |
| 05 Sep, 2025 | Douglas Kerr | Common Stock | D | 873 | $13.41 | 88,390 | D | S |
| 05 Sep, 2025 | Johanna Friedl-Naderer | Common Stock | D | 144 | $13.41 | 94,873 | D | S |
| 04 Sep, 2025 | Douglas Kerr | Common Stock | D | 3,552 | $13.27 | 89,263 | D | S |
| 04 Sep, 2025 | Johanna Friedl-Naderer | Common Stock | D | 894 | $13.27 | 95,017 | D | S |
| 15 Jul, 2025 | John Cox | Common Stock | D | 10,000 | $0.00 | 222,179 | D | G |
| 15 Jul, 2025 | John Cox | Common Stock | D | 10,000 | $0.00 | 18,000 | I | G |
| 15 Jul, 2025 | John Cox | - | - | 18,000 | I | |||
| 15 Jul, 2025 | John Cox | - | - | 18,000 | I | |||
| 15 Jul, 2025 | John Cox | Common Stock | D | 10,000 | $0.00 | 18,000 | I | G |
| 15 Jul, 2025 | John Cox | Common Stock | D | 10,000 | $0.00 | 232,179 | D | G |
| 14 Jul, 2025 | John Cox | Common Stock | A | 100,000 | $9.11 | 242,179 | D | P |
| 05 Jun, 2025 | John Cox | Common Stock | D | 4,060 | $13.35 | 142,179 | D | S |